Akèy › Kansè tete negatif triple › Virginia › Norfolk
Etid klinik pou Kansè tete negatif triple nan Norfolk, VA
5 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Norfolk (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Ap rekriteFaz 3
- Virginia Oncology Associates (VOA) ( Site 8002), Norfolk
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Ap rekriteFaz 3
- Virginia Oncology Associates (VOA) ( Site 8008), Norfolk
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Virginia Oncology Associates (VOA) ( Site 8008), Norfolk
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- USOR Virginia Oncology Associates, Norfolk
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Ap rekriteFaz 1/2
- Virginia Oncology Associates, Norfolk
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Norfolk
- Kansè nan tete16 etid
- Kansè vejik8 etid
- Kansè pwostat8 etid
- Aneurism aòtik abdominal7 etid
- Kansè ovè7 etid
- Kansè Poumon ki pa ti selil7 etid
- Kansè (tout kalite)7 etid
- Ensifizyans kadyak7 etid
- Maladi kadyovaskilè7 etid
- Atrofi miskilè spinal6 etid
- Maladi atè perifèrik5 etid
- Leksemi mieloïd egi5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.